Evaluation of epigenetic and metabolomic biomarkers indicating biological age
Authors:
- Lieke M. KuiperLKLieke M. Kuiper
- Harmke A. Polinder-BosHPHarmke A. Polinder-Bos
- Daniele BizzarriDBDaniele Bizzarri
- Dina VojinovicDVDina Vojinovic
- Costanza L. VallergaCVCostanza L. Vallerga
- Marian BeekmanMBMarian Beekman
- Martijn E.T. DolléMDMartijn E.T. Dollé
- Mohsen GhanbariMGMohsen Ghanbari
- Trudy VoortmanTrudy Voortman
- Marcel J.T. ReindersMarcel J.T. Reinders
- W.M. Monique VerschurenWVW.M. Monique Verschuren
- P. Eline SlagboomPSP. Eline Slagboom
Preprint
Abstract
Biological age captures a person’s age-related risk of unfavorable outcomes using biophysiological information. Multivariate biological age measures include frailty scores and molecular biomarkers. These measures are often studied in isolation, but here we present a large-scale study comparing them. In two prospective cohorts ( n =3,196), we compared epigenetic (DNAm Horvath, DNAm Hannum, DNAm PhenoAge, DNAm GrimAge) and metabolomic-based (MetaboAge, MetaboHealth) biomarkers in reflection of biological age, as represented by five frailty measures and overall mortality. We observed that mortality-trained biological age markers, DNAm GrimAge and MetaboHealth, outperformed age-trained biomarkers in frailty reflection and mortality prediction. The associations of DNAm GrimAge and MetaboHealth with frailty and mortality were independent of each other and of the frailty score mimicking clinical geriatric assessment. Epigenetic, metabolomic, and clinical biological age markers seem to capture different aspects of aging. These findings suggest that mortality-trained molecular markers may provide novel phenotype reflecting biological age and strengthen current clinical geriatric health and well-being assessment.Keywords
All Related Versions
This publication has 47 references indexed in Scilit:
- Association of frailty with survival: A systematic literature reviewAgeing Research Reviews, 2013
- Methods of data collection and definitions of cardiac outcomes in the Rotterdam StudyEuropean Journal of Epidemiology, 2012
- Comparing the Prognostic Accuracy for All-Cause Mortality of Frailty Instruments: A Multicentre 1-Year Follow-Up in Hospitalized Older PatientsPLOS ONE, 2012
- Aging, Rejuvenation, and Epigenetic Reprogramming: Resetting the Aging ClockCell, 2012
- High density DNA methylation array with single CpG site resolutionGenomics, 2011
- The Tilburg Frailty Indicator: Psychometric PropertiesJournal of the American Medical Directors Association, 2010
- Weighted statistics for aggregation and linkage analysis of human longevity in selected families: The Leiden Longevity StudyStatistics in Medicine, 2008
- Development and Validation of a Multidimensional Prognostic Index for One-Year Mortality from Comprehensive Geriatric Assessment in Hospitalized Older PatientsRejuvenation Research, 2008
- Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity StudyEuropean Journal of Human Genetics, 2005
- Accumulation of Deficits as a Proxy Measure of AgingThe Scientific World Journal, 2001